Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia

Journal of Vascular Surgery

Volumn 50, Issue 6, 2009, Pages

  Conte, Michael S ^a   Geraghty, Patrick J ^b   Bradbury, Andrew W ^c   Hevelone, Nathanael D ^a   Lipsitz, Stuart R ^d   Moneta, Gregory L ^e   Nehler, Mark R ^f   Powell, Richard J ^g   Sidawy, Anton N ^h  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^f UNIVERSITY OF COLORADO   (United States)

^g DARTMOUTH MEDICAL SCHOOL   (United States)

^h VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANATOMY; ARTICLE; CATHETER; CLINICAL TRIAL; DATA BASE; ENDOVASCULAR SURGERY; FEASIBILITY STUDY; FINANCIAL MANAGEMENT; HUMAN; LEG REVASCULARIZATION; LIMB AMPUTATION; LIMB ISCHEMIA; MEDICAL INSTRUMENTATION; METHODOLOGY; OUTCOME ASSESSMENT; PERFORMANCE; PERFORMANCE MEASUREMENT SYSTEM; PERIOPERATIVE PERIOD; POPULATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR; SAMPLE SIZE; SAPHENOUS VEIN; STANDARD; STRATIFICATION; SURGICAL MORTALITY; SURVIVAL; VEIN; VEIN BYPASS;

EID: 70649090106     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2009.09.044     Document Type: Article

References (22)

1. Norgren L., Hiatt W.R., Dormandy J.A., Nehler M.R., Harris K.A., Fowkes F.G., and TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 45 Suppl S (2007) S5-S67
2. Chen E., Sapirstein W., Ahn C., Swain J., and Zuckerman B. FDA perspective on clinical trial design for cardiovascular devices. Ann Thorac Surg 82 (2006) 773-775
3. Grunkemeier G.L., Jin R., and Starr A. Prosthetic heart valves: Objective Performance Criteria versus randomized clinical trial. Ann Thorac Surg 82 (2006) 776-780
4. Goode J., Sapirstein W., and Zuckerman B. FDA perspective on clinical trial design for femoropopliteal stent correction of peripheral vascular insufficiency cardiovascular devices. Catheter Cardiovasc Interv 69 (2007) 920-921
5. Rocha-Singh K.J., Jaff M.R., Crabtree T.R., Bloch D.A., Ansel G., VIVA Physicians, and Inc. Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease. Catheter Cardiovasc Interv 69 (2007) 910-919
6. Geraghty P.J., Matsumura J.S., and Conte M.S. Premarket assessment of devices for treatment of critical limb ischemia: the role of Objective Performance Criteria and Goals. J Vasc Surg 50 (2009) 1459-1461
7. Conte M.S., Bandyk D.F., Clowes A.W., Moneta G.L., Seely L., Lorenz T.J., et al. Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg 43 (2006) 742-751
8. Brass E.P., Anthony R., Dormandy J., Hiatt W.R., Jiao J., Nakanishi A., et al., Circulase Investigators. Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia. J Vasc Surg 43 (2006) 752-759
9. Nehler M.R., Brass E.P., Anthony R., Dormandy J., Jiao J., McNamara T.O., Hiatt W.R., and Circulase Investigators. Adjunctive parenteral therapy with lipo-ecraprost, a prostaglandin E1 analog, in patients with critical limb ischemia undergoing distal revascularization does not improve 6-month outcomes. J Vasc Surg 45 (2007) 953-960 discussion 960-1
10. Adam D.J., Beard J.D., Cleveland T., Bell J., Bradbury A.W., Forbes J.F., et al., BASIL trial participants. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 366 (2005) 1925-1934
11. Bradbury A., Wilmink T., Lee A.J., Bell J., Prescott R., Gillespie I., et al. Bypass versus angioplasty to treat severe limb ischemia: factors that affect treatment preferences of UK surgeons and interventional radiologists. J Vasc Surg 39 (2004) 1026-1032
12. Powell R.J., Dormandy J., Simons M., Morishita R., and Annex B.H. Therapeutic angiogenesis for critical limb ischemia: design of the hepatocyte growth factor therapeutic angiogenesis clinical trial. Vasc Med 9 (2004) 193-198
13. Powell R.J., Simons M., Mendelsohn F.O., Daniel G., Henry T.D., Koga M., et al. Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia. Circulation 118 (2008) 58-65
14. Conte M.S., Lorenz T.J., Bandyk D.F., Clowes A.W., Moneta G.L., and Seely B.L. Design and rationale of the PREVENT III clinical trial: edifoligide for the prevention of infrainguinal vein graft failure. Vasc Endovascular Surg 39 (2005) 15-23
15. Schanzer A., Hevelone N., Owens C.D., Belkin M., Bandyk D.F., Clowes A.W., et al. Technical factors affecting autogenous vein graft failure: observations from a large multicenter trial. J Vasc Surg 46 (2007) 1180-1190 discussion 1190
16. Lam R.C., Shah S., Faries P.L., McKinsey J.F., Kent K.C., and Morrissey N.J. Incidence and clinical significance of distal embolization during percutaneous interventions involving the superficial femoral artery. J Vasc Surg 46 (2007) 1155-1159
17. Shammas N.W., Dippel E.J., Coiner D., Shammas G.A., Jerin M., and Kumar A. Preventing lower extremity distal embolization using embolic filter protection: results of the PROTECT registry. J Endovasc Ther 15 (2008) 270-276
18. Laird J.R., Zeller T., Gray B.H., Scheinert D., Vranic M., Reiser C., Biamino G., and LACI Investigators. Limb salvage following laser-assisted angioplasty for critical limb ischemia: results of the LACI multicenter trial. J Endovasc Ther 13 (2006) 1-11
19. Bosiers M., Deloose K., Verbist J., and Peeters P. Nitinol stenting for treatment of "below-the-knee" critical limb ischemia: 1-year angiographic outcome after Xpert stent implantation. J Cardiovasc Surg (Torino) 48 (2007) 455-461
20. Giles K.A., Pomposelli F.B., Hamdan A.D., Blattman S.B., Panossian H., and Schermerhorn M.L. Infrapopliteal angioplasty for critical limb ischemia: relation of TransAtlantic InterSociety Consensus class to outcome in 176 limbs. J Vasc Surg 48 (2008) 128-136
21. Rutherford R.B., Baker J.D., Ernst C., Johnston K.W., Porter J.M., Ahn S., and Jones D.N. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 26 (1997) 517-538
22. Diehm N., Baumgartner I., Jaff M., Do D.D., Minar E., Schmidli J., et al. A call for uniform reporting standards in studies assessing endovascular treatment for chronic ischaemia of lower limb arteries. Eur Heart J 28 (2007) 798-805